(Q40852832)

24 September 2017

title

Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes (English)

1 reference

24 September 2017

P Pilie

1

1 reference

24 September 2017

W A Werbel

2

1 reference

24 September 2017

J Riddell

3

1 reference

24 September 2017

X Shu

4

1 reference

24 September 2017

D Schaubel

5

1 reference

24 September 2017

K S Gregg

6

1 reference

24 September 2017

publication date

6 July 2015

1 reference

Transplant Infectious Disease

24 September 2017

published in

1 reference

24 September 2017

volume

17

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

551-557

1 reference

Respiratory syncytial virus in young children

24 September 2017

cites work

1 reference

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

21 January 2018

1 reference

Respiratory syncytial virus infection in elderly and high-risk adults

21 January 2018

1 reference

Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease

21 January 2018

1 reference

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

21 January 2018

1 reference

Risk factors for severe respiratory syncytial virus infection in elderly persons

21 January 2018

1 reference

Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes

21 January 2018

1 reference

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome

21 January 2018

1 reference

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

21 January 2018

1 reference

Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection

21 January 2018

1 reference

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

21 January 2018

1 reference

Respiratory syncytial virus infection following hematopoietic stem cell transplantation

21 January 2018

1 reference

Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.

21 January 2018

1 reference

Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients

21 January 2018

1 reference

Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness

21 January 2018

1 reference

Polymerase-chain-reaction-based diagnosis of viral pulmonary infections in immunocompromised children.

21 January 2018

1 reference

Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease

21 January 2018

1 reference

Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients

21 January 2018

1 reference

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

21 January 2018

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.

21 January 2018

1 reference

Challenges and opportunities in developing respiratory syncytial virus therapeutics

21 January 2018

1 reference

Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.

21 January 2018

1 reference

Oral GS-5806 activity in a respiratory syncytial virus challenge study.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TID.12409

1 reference

24 September 2017

1 reference